重新发现多发性骨髓瘤中的静血异常:新时代的新时代
Yudie Huang1,2, Chongyu Wang2, Hua Wang3
1Department of Hematology, Affiliated Hospital of Nantong University, Jiangsu, 226001, China.
Heliyon
|July 26, 2024
概括
多发性骨髓瘤 (MM) 患者因疾病和治疗而面临出血和凝血风险. 本综述探讨了新疗法如何影响血液静止,并提出了预防策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性骨髓瘤 (MM) 是一种与显著出血和血栓风险相关的血细胞恶性瘤.
- 在MM中血静失衡是由于疾病,患者和与药物相关的因素影响凝血和纤维素分解而产生的.
- 最近MM治疗的进步引入了可能进一步影响血液静止的新药.
研究的目的:
- 审查多发性骨髓瘤中血液静止异常背后的机制.
- 评估新型MM疗法对静血平衡的影响.
- 讨论可靠的预防和治疗策略,以管理MM患者的血液静止障碍.
主要方法:
- 关于多发性骨髓瘤病理生理学和血静的研究的文献综述.
- 对临床数据的分析和对新型MM治疗及其对凝血的影响的研究.
- 综合有关药物诱导的血静变化和管理方法的信息.
主要成果:
- 多发性骨髓瘤通过疾病特异性,患者特异性和与药物相关的机制显著破坏血静.
- 新兴的MM疗法,包括单克隆抗体和向药物,与血液静止有复杂的相互作用.
- 了解这些相互作用对于优化患者的治疗结果和预防并发症至关重要.
结论:
- 血静异常是多发性骨髓瘤管理中的一个关键问题.
- 新的MM治疗需要仔细监测血静性改变.
- 积极的策略对于减轻MM患者接受新疗法的出血和血栓风险至关重要.
相关概念视频
Disorders of Hemostasis
795
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
795
Anticoagulant Drugs: Low-Molecular-Weight Heparins
663
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
663
Disorders of Leukocytes
924
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
924
Bone Marrow Sampling and Transplants
318
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
318
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Introduction to Hemostasis
7.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.0K


